Kobayashi Pharmaceutical Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Kobayashi Pharmaceutical stock has a consensus rating of "Hold" and an average price target of ¥5,496. The average 1-year stock price forecast is 1.25% lower than the current stock price, while the lowest is ¥3,950 (-29.03%) and the highest is ¥6,700 (+20.37%).

Price Target: ¥5,496 (-1.25%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	¥3,950	¥5,496	¥5,450	¥6,700
Change	-29.03%	-1.25%	-2.08%	+20.37%

* Price targets were last updated on Apr 17, 2026.

Analyst Ratings

The average analyst rating for Kobayashi Pharmaceutical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	5	4	4	4	4	4
Sell	0	0	0	1	1	1
Strong Sell	1	1	1	1	1	1
Total	8	7	7	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Hisae Kawamoto Jefferies	Jefferies	Hold Maintains ¥5,200	Hold	Maintains	¥5,200	-6.58%	Apr 17, 2026
Unknown Analyst Morgan Stanley No rating	Morgan Stanley	Sell Maintains ¥5,281	Sell	Maintains	¥5,281	-5.12%	Jan 16, 2026

Financial Forecast

Revenue This Year

172.75B

from 165.74B

4.23%

from 165.74B

Revenue Next Year

180.08B

from 172.75B

4.24%

from 172.75B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	155.25B	166.26B	173.46B	165.60B	165.74B	172.75B
Revenue Growth	3.15%	7.09%	4.33%	-4.53%	0.09%	4.23%
Gross Profit	88.77B	92.33B	96.38B	87.60B	84.71B	88.71B
Gross Margin	57.18%	55.53%	55.56%	52.90%	51.11%	51.35%
Operating Income	25.95B	26.51B	25.63B	24.71B	14.85B	13.43B
Net Income	19.72B	20.02B	20.34B	10.07B	3.66B	10.44B
Dividend / Share	83.00	90.00	101.00	102.00	104.00	106.00
Dividend Growth	-	8.43%	12.22%	0.99%	1.96%	1.92%
Free Cash Flow	14.51B	11.18B	2.53B	-13.06B	18.25B	14.84B
No. Analysts	-	-	-	-	-	8

Financial currency is JPY.

Revenue Forecast

Revenue	2026	2027	2028
High	173.8B
Avg	172.8B
Low	171.3B

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.9%
Avg	4.2%
Low	3.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-